Susceptibility of Gambian Adults to PfSPZ-Challenge Infection in the Controlled Human Malaria Infection Model
- Status
- COMPLETED
- Phase
- NA
Clinical Trials Related to Malaria
Related studies linked through entity extraction aliases.
Safety and Pharmacokinetics Study of DM1157 to Treat Malaria
- Status
- TERMINATED
- Phase
- PHASE1
Dynamics of Subclinical Malaria: Preliminary Study
- Status
- COMPLETED
- Phase
- N/A
Study Assessing Pharmacokinetics and Bioavailability of Three Novel Triazine Compounds
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Preventing Mental Health Problems After Childhood Severe Malaria
- Status
- COMPLETED
- Phase
- NA
Study to Evaluate Safety, Immunogenicity and Efficacy of PfSPZ Vaccine in HIV Negative and HIV Positive Tanzanian Adults
- Status
- COMPLETED
- Phase
- PHASE1
Aggressive Antipyretics for Fever Reduction in CNS Malaria
- Status
- COMPLETED
- Phase
- PHASE2
Malaria Genetic Surveillance in Cambodia
- Status
- COMPLETED
- Phase
- N/A
Single Low-dose Primaquine Efficacy and Safety.
- Status
- COMPLETED
- Phase
- PHASE4
Trial to Evaluate the Safety, Immunogenicity, and Efficacy of Malaria Infection in Malaria Naïve Adults
- Status
- COMPLETED
- Phase
- PHASE1
Safety of KAE609 in Adults With Uncomplicated Plasmodium Falciparum Malaria.
- Status
- COMPLETED
- Phase
- PHASE2
Community Dynamics of Malaria Transmission and Mosquito Feeding in Bancoumana, Mali
- Status
- COMPLETED
- Phase
- N/A
Molecular Basis of Erythrocyte Invasion by Plasmodium Vivax Into Duffy-Negative Erythrocytes in Mali
- Status
- COMPLETED
- Phase
- N/A
Study to Assess the Vaccine Efficacy Against Malaria Infection, in Children Immunized With the Primary and Yearly Booster of the RTS,S/AS01E Vaccine, as Part of Their Participation in the Malaria-094 (204889/NCT03276962) Study.
- Status
- COMPLETED
- Phase
- N/A
Chloroquine (CQ) and Azithromycin (AZ) Combination for Malaria Prophylaxis
- Status
- WITHDRAWN
- Phase
- PHASE2
Efficacy, Safety and Immunogenicity Study of GSK Biologicals' Candidate Malaria Vaccine (SB257049) Evaluating Schedules With or Without Fractional Doses, Early Dose 4 and Yearly Doses, in Children 5-17 Months of Age
- Status
- COMPLETED
- Phase
- PHASE2
Empirical ANtibiotic THErapy in Adults Hospitalised With Malaria
- Status
- COMPLETED
- Phase
- N/A
Prevalence Survey of Antimalarial Drug Resistance Markers
- Status
- COMPLETED
- Phase
- N/A
Improving PRegnancy Outcomes With Intermittent preVEntive Treatment in Africa
- Status
- COMPLETED
- Phase
- PHASE3
A Safety and Efficacy Study of ChAdOx1 LS2 and MVA LS2
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2